| __timestamp | Bristol-Myers Squibb Company | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 1488000000 |
| Thursday, January 1, 2015 | 5920000000 | 1525000000 |
| Friday, January 1, 2016 | 4940000000 | 2111000000 |
| Sunday, January 1, 2017 | 6411000000 | 1848000000 |
| Monday, January 1, 2018 | 6345000000 | 1213000000 |
| Tuesday, January 1, 2019 | 6148000000 | 1010000000 |
| Wednesday, January 1, 2020 | 11143000000 | 997000000 |
| Friday, January 1, 2021 | 10195000000 | 967000000 |
| Saturday, January 1, 2022 | 9509000000 | 838000000 |
| Sunday, January 1, 2023 | 9299000000 | 953000000 |
| Monday, January 1, 2024 | 11159000000 | 998000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Bristol-Myers Squibb Company and Teva Pharmaceutical Industries Limited have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Bristol-Myers Squibb consistently outpaced Teva, with R&D expenses peaking in 2020 at nearly double their 2014 levels. This surge reflects a strategic focus on pioneering treatments and expanding their therapeutic portfolio. In contrast, Teva's R&D spending showed a downward trend, decreasing by approximately 36% from 2016 to 2023. This reduction may indicate a shift towards cost optimization or a strategic pivot in their business model. As the pharmaceutical landscape continues to shift, these investment patterns offer a glimpse into the strategic priorities of two industry giants, highlighting the critical role of R&D in shaping the future of healthcare.
Novo Nordisk A/S or Teva Pharmaceutical Industries Limited: Who Invests More in Innovation?
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Analyzing R&D Budgets: Novartis AG vs Bristol-Myers Squibb Company
Gross Profit Comparison: Bristol-Myers Squibb Company and Teva Pharmaceutical Industries Limited Trends
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and ACADIA Pharmaceuticals Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Neurocrine Biosciences, Inc. Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated
R&D Insights: How Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc. Allocate Funds
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited vs MannKind Corporation: Strategic Focus on R&D Spending